Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab

Detalles Bibliográficos
Autores principales: Requena, Gema, Roufosse, Florence, Baylis, Lee D., Steinfeld, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780009/
https://www.ncbi.nlm.nih.gov/pubmed/33425360
http://dx.doi.org/10.1002/rcr2.707
_version_ 1783631431627440128
author Requena, Gema
Roufosse, Florence
Baylis, Lee D.
Steinfeld, Jonathan
author_facet Requena, Gema
Roufosse, Florence
Baylis, Lee D.
Steinfeld, Jonathan
author_sort Requena, Gema
collection PubMed
description
format Online
Article
Text
id pubmed-7780009
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-77800092021-01-08 Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab Requena, Gema Roufosse, Florence Baylis, Lee D. Steinfeld, Jonathan Respirol Case Rep Correspondence John Wiley & Sons, Ltd 2021-01-04 /pmc/articles/PMC7780009/ /pubmed/33425360 http://dx.doi.org/10.1002/rcr2.707 Text en © 2021 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Requena, Gema
Roufosse, Florence
Baylis, Lee D.
Steinfeld, Jonathan
Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
title Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
title_full Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
title_fullStr Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
title_full_unstemmed Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
title_short Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
title_sort response to a case report: idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780009/
https://www.ncbi.nlm.nih.gov/pubmed/33425360
http://dx.doi.org/10.1002/rcr2.707
work_keys_str_mv AT requenagema responsetoacasereportidiopathichypereosinophilicsyndromeinremissionwithbenralizumabtreatmentafterrelapsewithmepolizumab
AT roufosseflorence responsetoacasereportidiopathichypereosinophilicsyndromeinremissionwithbenralizumabtreatmentafterrelapsewithmepolizumab
AT baylisleed responsetoacasereportidiopathichypereosinophilicsyndromeinremissionwithbenralizumabtreatmentafterrelapsewithmepolizumab
AT steinfeldjonathan responsetoacasereportidiopathichypereosinophilicsyndromeinremissionwithbenralizumabtreatmentafterrelapsewithmepolizumab

Ejemplares similares